Tajuk : The Supreme Court just issued a big win for new drugs that could save the US billions
link : The Supreme Court just issued a big win for new drugs that could save the US billions
The Supreme Court just issued a big win for new drugs that could save the US billions
REUTERS/Kevin Lamarque
U.S. Supreme Court Justice Clarence Thomas, who delivered the opinion, arrives for inauguration ceremonies in 2013.
WASHINGTON — The US Supreme Court on Monday cut the time it will take for copycat versions of biologic drugs — known as biosimilars — to get to the market in a pivotal ruling about an expensive class of medicines that can yield billions of dollars in sales for drug companies.
The justices, in a 9-0 ruling, overturned a lower court decision that had prevented Swiss pharmaceutical company Novartis from selling its copycat version of California-based Amgen’s Neupogen until six months after the U.S. Food and Drug Administration approved it.
Biosimilars are a bit more complicated than your average competing medicine: Unlike generics for chemical-based drugs like antibiotics that can be interchangeable with branded versions, the copycats of biologic medications, produced using living cells, have a few more caveats.
As it stands right now, biosimilars can’t be used interchangeably with branded versions, meaning if you were to get a prescription for a branded biologic, you wouldn’t be able to opt for the “generic” one at the pharmacy as easily as you could if the drug was, say, a statin.
It also takes more time, energy, and money to get a biosimilar approved, compared to a generic medicine. To develop a biosimilar, it usually takes about eight years and can costs about $250 million. In comparison, a generic takes a quarter of that time (about two years) and costs a tenth of the price ($5 million) to produce.
Having more biosimilars on the market faster — without waiting six months — would be a big deal. It might be the best way to drive down the cost of biologic medications that have been around for a while. The savings of putting people on far less costly biosimilars — even just new patients who have never taken the original — are estimated to be billions of dollars. Express Scripts, a pharmacy benefit manager, estimated in 2013 that the US could be saving $250 billion over the next 10 years because of biosimilars.
Reuters reporting by Andrew Chung.
Read more stories on Business Insider, Malaysian edition of the world’s fastest-growing business and technology news website.
✍ Sumber Pautan : ☕ Business InsiderBusiness Insider
Kredit kepada pemilik laman asal dan sekira berminat untuk meneruskan bacaan sila klik link atau copy paste ke web server : http://ift.tt/2rn93gk
(✿◠‿◠)✌ Mukah Pages : Pautan Viral Media Sensasi Tanpa Henti. Memuat-naik beraneka jenis artikel menarik setiap detik tanpa henti dari pelbagai sumber. Selamat membaca dan jangan lupa untuk 👍 Like & 💕 Share di media sosial anda!
Thus Article The Supreme Court just issued a big win for new drugs that could save the US billions
Anda sedang baca artikel The Supreme Court just issued a big win for new drugs that could save the US billions dengan alamat pautan https://johorbaharunews.blogspot.com/2017/06/the-supreme-court-just-issued-big-win.html
Related Posts :
Tidak Bertolak Ansur , Hanya Kaut Keuntungan ! Mood Rebuplik Festivel No 1 Paling Biadap Di Malaysia - Saiful Nang- Seaweed could be the key to long-lasting electric car batteries
- Blue Apron plans to raise up to $587 million as it goes public
- Elon Musk is getting closer to making his Los Angeles tunnel network a reality
- Buat Aduan Jika Terbeli Beras Dicampur Plastik
0 Response to "The Supreme Court just issued a big win for new drugs that could save the US billions"
Catat Ulasan